¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"d"¿¡ ´ëÇÑ ´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • DABITC
    (å²) 4-dimethylaminoazobenzene-4'-isothiocyante
  • dactinomycin
    ´ÚƼ³ë¸¶À̽Å(ÔÒ) actinomycin D
  • DALA
    (å²) -aminolevulinic acid
  • dalton
    µ¹Åæ[Ó¤êÈ]
  • Dane particle
    ´ëÀÎ ÀÔÀÚ(Ø£í­)
  • Danielli-Davson model
    ´Ù´Ï¿¤¸®-´ëºê¼Õ ¸ðµ¨
  • Danielli-Davson-Robertson model
    "= unit membrane hypothesis, ´Ù´Ï¿¤¸®-´ëºê¼Õ-·Î¹öÆ®¼Õ ¸ðµ¨"
  • dansyl amino acid
    ´í½Ç ¾Æ¹Ì³ë»ê(ß«)
  • dansylation
    ´í½ÇÈ­(ûù)
  • Danysz phenomenon
    ´ë´ÏÁî Çö»ó(úÞßÚ)
  • DAP pathway
    "DAP °æ·Î(ÌèÖØ) (ÔÒ) diaminopimelate pathway,"
  • dark reaction
    ¾Ï¹ÝÀÀ(äÞÚãëë)
  • dark reactivation
    ¾Ï ÀçȰ¼ºÈ­(äÞî¢üÀàõûù)
  • dark recovery
    ¾Ï ȸº¹(äÞüÞÜÖ) (ÔÒ) dark reactivation
  • dark repair
    "¾Ï¼öº¹(äÞáóÜÖ), (ÔÒ) dark reactivation"
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á